Paul J. Isaac Acquires 38,000 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) Stock

Stereotaxis, Inc. (NYSEAMERICAN:STXS - Get Free Report) Director Paul J. Isaac bought 38,000 shares of the stock in a transaction on Monday, March 10th. The stock was purchased at an average price of $1.81 per share, for a total transaction of $68,780.00. Following the completion of the purchase, the director now directly owns 87,299 shares in the company, valued at approximately $158,011.19. This represents a 77.08 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Stereotaxis Trading Up 1.1 %

Shares of STXS traded up $0.02 during mid-day trading on Tuesday, reaching $1.79. 785,014 shares of the stock traded hands, compared to its average volume of 461,650. The firm has a market cap of $151.67 million, a P/E ratio of -6.39 and a beta of 1.54. Stereotaxis, Inc. has a 1 year low of $1.66 and a 1 year high of $3.29. The business has a fifty day simple moving average of $2.26.

Hedge Funds Weigh In On Stereotaxis

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Charles Schwab Investment Management Inc. increased its holdings in shares of Stereotaxis by 10.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company's stock worth $341,000 after buying an additional 15,491 shares during the last quarter. State Street Corp lifted its stake in Stereotaxis by 5.7% during the third quarter. State Street Corp now owns 680,612 shares of the company's stock worth $1,388,000 after purchasing an additional 36,518 shares during the last quarter. Jane Street Group LLC increased its position in shares of Stereotaxis by 26.9% during the 3rd quarter. Jane Street Group LLC now owns 29,773 shares of the company's stock valued at $61,000 after purchasing an additional 6,313 shares during the last quarter. Barclays PLC lifted its position in Stereotaxis by 449.9% in the 3rd quarter. Barclays PLC now owns 101,953 shares of the company's stock worth $208,000 after buying an additional 83,412 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in Stereotaxis by 7.2% in the third quarter. Geode Capital Management LLC now owns 1,391,718 shares of the company's stock worth $2,840,000 after buying an additional 93,253 shares in the last quarter. 45.35% of the stock is currently owned by hedge funds and other institutional investors.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Remove Ads